Gout

Ultrasound shows rapid reduction of crystal depositions during a treat-to-target approach in gout patients: 12-month results from the NOR-Gout study
Hilde Berner Hammer, Lars Karoliussen, Lene Terslev, Espen A Haavardsholm, Tore K Kvien, Till Uhlig

Annals of the Rheumatic Diseases Nov 2020, 79 (11) 1500-1505; DOI: 10.1136/annrheumdis-2020-217392
Gout and pseudo-gout-related crystals promote GLUT1-mediated glycolysis that governs NLRP3 and interleukin-1β activation on macrophages
Felix Renaudin, Lucie Orliaguet, Florence Castelli, François Fenaille, Aurelie Prignon, Fawaz Alzaid, Christele Combes, Aurélie Delvaux, Yasmina Adimy, Martine Cohen-Solal, Pascal Richette, Thomas Bardin, Jean-Pierre Riveline, Nicolas Venteclef, Frédéric Lioté, Laure Campillo-Gimenez, Hang-Korng Ea

Annals of the Rheumatic Diseases Nov 2020, 79 (11) 1506-1514; DOI: 10.1136/annrheumdis-2020-217342
Response to: ‘Correspondence on ‘Ultrasound shows rapid reduction of crystal depositions during a treat-to-target approach in gout patients: 12-month results from the NOR-Gout study’’ by Hung et al
Hilde Berner Hammer, Lars Fridtjof Karoliussen, Lene Terslev, Espen A Haavardsholm, Tore K Kvien, Till Uhlig

Annals of the Rheumatic Diseases Sep 2020, annrheumdis-2020-218908; DOI: 10.1136/annrheumdis-2020-218908
Correspondence on ‘Ultrasound shows rapid reduction of crystal depositions during a treat-to-target approach in gout patients: 12-month results from the NOR-Gout study’
Po-Cheng Hung, Da-Hung Lin, Amy Ker, Chieh-Chun Yang, Hung-Wan Chien, James Cheng-Chung Wei

Annals of the Rheumatic Diseases Sep 2020, annrheumdis-2020-218846; DOI: 10.1136/annrheumdis-2020-218846
Incidence trend of five common musculoskeletal disorders from 1990 to 2017 at the global, regional and national level: results from the global burden of disease study 2017
Ziyi Jin, Dandan Wang, Huayong Zhang, Jun Liang, Xuebing Feng, Jinkou Zhao, Lingyun Sun

Annals of the Rheumatic Diseases Aug 2020, 79 (8) 1014-1022; DOI: 10.1136/annrheumdis-2020-217050
Cutaneous adverse events with febuxostat after previous reactions to allopurinol: comment on the article by Singh and Cleveland
Neus Quilis, Paloma Vela, Boris A Blanco Cáceres, Cesar Diaz-Torne, Enrique Calvo-Aranda, Francisca Sivera, Alejandro Prada-Ojeda, Fernando Pérez Ruiz, Eliseo Pascual, Mariano Andrés

Annals of the Rheumatic Diseases Jul 2020, annrheumdis-2020-218226; DOI: 10.1136/annrheumdis-2020-218226
Hypersensitivity reactions with allopurinol versus febuxostat in the US elderly. Response to: ‘Confunding by indication and ethnicity difference? Comment on ‘Hypersensitivity reactions with allopurinol and febuxostat: a study using the Medicare claims data’’ by Hsu et al
Jasvinder A Singh

Annals of the Rheumatic Diseases Jun 2020, annrheumdis-2020-218150; DOI: 10.1136/annrheumdis-2020-218150
Correspondence to ‘Hypersensitivity reactions with allopurinol and febuxostat: a study using the Medicare claims data’
Kevin Sheng-Kai Ma, James Cheng-Chung Wei, Wen-Hung Chung

Annals of the Rheumatic Diseases Jun 2020, annrheumdis-2020-218090; DOI: 10.1136/annrheumdis-2020-218090
Confounding by indication and ethnicity difference? Comment on ‘Hypersensitivity reactions with allopurinol and febuxostat: a study using the Medicare claims data’
Po-Ke Hsu, Yung-Heng Lee, James Cheng Chung Wei

Annals of the Rheumatic Diseases Jun 2020, annrheumdis-2020-218056; DOI: 10.1136/annrheumdis-2020-218056
Allopurinol versus febuxostat hypersensitivity reactions in the US elderly: differences in study outcomes and populations. Response to: ‘Correspondence to “Hypersensitivity reactions with allopurinol and febuxostat: a study using the Medicare claims data’ by Ma et al
Jasvinder A Singh

Annals of the Rheumatic Diseases Jun 2020, annrheumdis-2020-218149; DOI: 10.1136/annrheumdis-2020-218149

Main menu

Gout

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

Gout

Pages